Health Condition 1: null- Diagnosed case of cerebrovascular sinus thrombosis
Conditions
Interventions
None listed
Sponsors
Pfizer Limited
Eligibility
Inclusion criteria
Inclusion criteria: 1. Males and females between 18 and 65 years of age. 2. Cerebral venous thrombosis confirmed by cerebral angiography (with intra-arterial contrast injection) or magnetic resonance venography or computed tomographic venography. 3. Patients or authorized representative must be able and willing to provide written informed consent. 4. Patients who are willing to or likely to comply with all study requirements. Inclusion for Control Arm Subjects 1. Age and gender matched healthy individuals from community or hospital patients with minor illnesses from general OPD without any neurological conditions or previous history of thrombosis or CVST who is willing to participate. 2. Males and females between 18 and 65 years of age. 3. Patients or authorized representative must be able and willing to provide written informed consent. 4. Patients who are willing to or likely to comply with all study requirements.
Exclusion criteria
Exclusion criteria: 1. Any known associated condition (such as cancer) with a poor short term (1 year) (terminal illness) prognosis independent of CVST. 2. Recent ( 3. Patients who are unlikely to comply with protocol requirements (e.g., non-cooperative behavior, inability to attend the protocol visits). 4. Patients who are currently participating or had participated in other interventional study for last 30 days prior to their enrollment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| â?¢ The percentage of CVST patients with nutritional deficiencies as compared to normal population. â?¢ The percentage of CVST patients with abnormal thrombotic profile as compared to normal population.Timepoint: At baseline (1st visit i.e. study enrollment) | — |
Secondary
| Measure | Time frame |
|---|---|
| â?¢ The percentage of CVST patients with long term sequelae such as epilepsy, headaches, visual loss, pyramidal deficits and cognitive impairment. â?¢ The percentage of CVST patients with recurrence of CVST episode particularly after the first 12 months of the first episode, disability and death (as assessed by Modified Rankin Scale). Timepoint: 12 months | — |
Countries
India
Contacts
Public ContactDr PG Divate
Jehangir Clinical Development Centre
Outcome results
None listed